More on the Tax-Cuts-and-Medicaid-Cuts Bill, Including an Apex Analysis of a Biotech-Boosting R&D Tax Provision
Shares:
Look, there’s not much going on today, so I won’t waste your time with a lot of fluff. In the absence of actual news, I’m paying close attention to potential
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
Fair warning: the rest of the week might be heavy on 340B. It’s a topic that is very hip, very 2025. ICER has decided that its next big research effort